tiprankstipranks
Mynd Life Sciences Inc (MYNDF)
:MYNDF
US Market
Holding MYNDF?
Track your performance easily

MYND Life Sciences (MYNDF) Income Statement

1 Followers

MYND Life Sciences Income Statement

Last quarter (Q3 2024), MYND Life Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, MYND Life Sciences's net income was $-379.27K. See MYND Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Oct 22Oct 21
Total Revenue
$ 1.00$ ―$ ―$ ―
Cost of Revenue
$ -180.00K$ ―$ 180.00K$ ―
Gross Profit
$ 180.00K$ ―$ -180.00K$ ―
Operating Expense
$ 1.29M$ 1.83M$ 2.88M$ 4.29M
Operating Income
$ -1.29M$ -1.83M$ -3.06M$ -4.29M
Net Non Operating Interest Income Expense
$ -235.08K$ -728.41K$ -662.90K$ 134.88K
Other Income Expense
$ -981.84K$ -1.04M$ 28.93K$ -109.05K
Pretax Income
$ -542.57K$ -1.52M$ -3.70M$ -4.54M
Tax Provision
$ ―$ ―$ -129.95K$ -168.31K
Earnings From Equity Interest Net Of Tax
$ ―$ ―$ ―$ ―
Net Income Common Stockholders
$ -542.57K$ -1.52M$ -3.57M$ -4.37M
Basic EPS
$ -0.04$ -0.06$ -0.16$ -0.10
Diluted EPS
-$ ―$ ―$ -0.10
Basic Average Shares
$ 189.32M$ 47.27M$ 46.68M$ 44.96M
Diluted Average Shares
$ 189.32M$ 47.27M$ 46.68M$ 44.96M
Dividend Per Share
$ ―$ ―$ ―$ ―
Total Operating Income As Reported
$ ―$ ―$ ―$ ―
Reported Normalized Basic E P S
$ ―$ ―$ ―$ ―
Reported Normalized Diluted E P S
$ ―$ ―$ ―$ ―
Rent Expense Supplemental
$ ―$ ―$ ―$ ―
Total Expenses
$ ―$ ―$ ―$ -4.29M
Net Income From Continuing And Discontinued Operation
$ -542.57K$ -1.52M$ -3.57M$ -4.37M
Normalized Income
$ -639.29K$ -1.12M$ -3.84M$ -4.59M
Interest Expense
$ ―$ ―$ ―$ ―
EBIT
$ -307.48K$ -789.45K$ -3.03M$ -4.40M
EBITDA
$ -306.09K$ 20.99B$ -2.97M$ -4.31M
Currency in USD

MYND Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis